Compare Edwards Lifesciences Corporation Common Stock (EW) vs Kinross Gold Corporation (KGC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Edwards Lifesciences Corporation Common Stock vs Kinross Gold Corporation — how do they compare? Edwards Lifesciences Corporation Common Stock trades at $84.25 (market cap $49.44B), while Kinross Gold Corporation trades at $23.89 (market cap $27.57B). The key difference: Edwards Lifesciences Corporation Common Stock is the larger of the two by market cap, and Kinross Gold Corporation pays a 0.69% dividend while Edwards Lifesciences Corporation Common Stock pays none. Which is the better fit depends on your goals.
| EW | KGC | |
|---|---|---|
Market Cap | $49.44B | $27.57B |
Volume | 3,508,027 | 6,413,529 |
Sector | Health | Basic Materials |
52-Week High | $95.18 | $38.06 |
52-Week Low | $72.65 | $22.47 |
Enterprise Value | $45.90B | $25.66B |
Typical Hold Time | — | 53 Days |
Dividend Yield | — | 0.69% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Kinross Gold (KGC) trades at $23.34, down 1.97% with bearish technical signals despite strong fundamentals. The company reported robust Q2 2026 earnings of $0.71 per share, beating expectations, and maintains impressive profitability with 37.52% net income margin. Recent news highlights production guidance cuts at La Coipa and Round Mountain mines, causing stock volatility, while the company increases shareholder returns to 50% of free cash flow.
KGC presents a valuation opportunity with low P/E of 8.81 and strong cash flow growth, but faces near-term headwinds from operational challenges and multiple fraud investigations. Analyst consensus remains bullish with $39.20 price target, representing 68% upside potential, though technical indicators suggest continued pressure. The stock's direction will hinge on operational execution and gold price stability.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Edwards Lifesciences Corporation Common Stock
Edwards Lifesciences develops medical technologies for structural heart disease. Its products include transcatheter aortic-valve replacement, mitral and tricuspid therapies, and surgical structural-heart technologies.
Read more on EW →About Kinross Gold Corporation
Kinross Gold is a Canada-based senior gold producer, producing roughly 2.4 million gold equivalent ounces in 2020. The company had 30 million ounces of proven and probable gold reserves and 59 million ounces of silver reserves at the end of 2020. It operates mines and focuses its greenfield and brownfield exploration in the Americas, West Africa, and Russia. The company has historically used acquisitions to fuel expansion into new regions and production growth.
Read more on KGC →
